DAVIS, Calif., Nov. 22, 2021 /PRNewswire/ -- Arcadia
Biosciences, Inc.® (Nasdaq: RKDA), a producer and
marketer of innovative, plant-based health and wellness products,
announced it has named Brian
Schaffer as senior vice president of sales, as the company
continues to expand its consumer goods platforms.
A seasoned sales and general management executive with deep CPG
experience, Schaffer has a proven track record of building and
leading world class sales organizations. He is tasked with driving
the retail launch of Arcadia's
GoodWheat brand, a company priority in 2022 as it works to build
out its portfolio of plant-based, better-for-you products.
"Brian's expertise comes at a critical time for the company, as
we establish our brands in an increasingly competitive and rapidly
evolving retail environment," said Matt
Plavan, Arcadia CEO. "I'm confident in Brian's
commitment to lead our sales team and execute a successful retail
launch of GoodWheat, leveraging his retail channel relationships,
proven leadership and growth-oriented mindset. His experience and
passion for building brands will enable us to continue to grow
Zola® coconut water and our portfolio of natural body
care products including Saavy Naturals®, SoulSpring™ and
ProVault™."
With a CPG pedigree that includes leadership roles at PepsiCo
and Kellogg's, Schaffer possesses comprehensive knowledge across
categories, channels of trade and go-to-market systems. Throughout
his extensive career, he has successfully developed and executed
growth strategies for brands including Keebler Chips Deluxe, Cheez
It, Gatorade, Tropicana, Quaker Foods & Snacks and On The
Border tortilla chips and salsas.
"I am delighted to join a dynamic, world class team," said
Schaffer. "The impressive work that's been done by the team thus
far has readied the innovative GoodWheat products for launch, and
I'm excited to build the brand at retail. In addition, I see
significant opportunity for continued retail growth of the existing
Arcadia portfolio of on-trend,
plant-based beverage and body care products."
Arcadia's chief growth officer,
Chris Cuvelier, will be leaving the
company effective November 30 to
pursue other opportunities. "I am proud of the work we have done at
Arcadia to integrate Zola and the
body care brands into our portfolio of wellness products and set
the foundation for continued growth," said Cuvelier. "Brian is a
strong addition to our leadership team with his proven ability to
build and successfully execute CPG sales strategies, and I am
confident he will continue to successfully build on the foundation
we have set."
About Arcadia Biosciences, Inc.
With origins as a trailblazing developer of science-based
approaches to enhancing the quality and nutritional value of crops
and food ingredients, Arcadia Biosciences (Nasdaq: RKDA) is now a
producer of innovative, plant-based health and wellness products,
including GoodWheat™, Soul Spring™,
ProVault™, Saavy Naturals® and
Zola® coconut water. The company's growing number
of offerings are designed to enhance quality and health benefits in
an array of consumer product categories. For more information,
visit www.arcadiabio.com.
Note Regarding Forward-Looking Statements
This press
release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of
1995, including statements regarding the retail launch of
GoodWheat, sales growth and product awareness and innovation.
Forward-looking statements are subject to risks and uncertainties
that could cause actual results to differ materially, and reported
results should not be considered as an indication of future
performance. These risks and uncertainties include, but are not
limited to: Arcadia's and its
partners' and affiliates' ability to develop commercial products
incorporating their traits, and complete the regulatory review
process for such products; customer demand and commercial success
of such products; Arcadia's
compliance with laws and regulations that impact Arcadia's business, including the sale of
products containing CBD, and changes to such laws and regulations;
Arcadia's future capital
requirements and ability to satisfy its capital needs; Arcadia's ability to develop, enforce and
defend its intellectual property rights; and the other risks set
forth in Arcadia's filings with
the Securities and Exchange Commission from time to time, including
the risks set forth in Arcadia's
Annual Report on Form 10-K for the year ended December 31, 2020 and other filings. These
forward-looking statements speak only as of the date hereof, and
Arcadia Biosciences, Inc. disclaims any obligation to update these
forward-looking statements.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-appoints-seasoned-cpg-sales-executive-brian-schaffer-to-senior-vice-president-of-sales-301429526.html
SOURCE Arcadia Biosciences, Inc.